Obagi Medical Products has doubling profits on product sales…Obagi Medical Products trades on the “NASDAQ” under the Stock Symbol “OMPI”. For the Latest information regarding “OMPI”, make sure to visit the Most Exclusive and In Depth newsletter website at: http://www.wallstreetgrand.com/.
Join today and be part of the best free investment newsletter on the web where we focus on market moving news.
Obagi Medical Products, (NASDAQ:OMPI) which makes prescription-strength and over-the-counter skin creams, said Thursday its fourth-quarter profit doubled on stronger sales and lower costs. The company earned $4.8 million, or 22 cents per share, up from $2.2 million, or 10 cents per share, during the same period a year prior. Sales rose 21 percent to $30.7 million from $25.4 million
The company's Nu-Derm System includes prescription and over-the-counter treatments for wrinkles, acne, and other skin conditions. Sales of Nu-Derm rose 18 percent to $17 million. Meanwhile, operating expenses fell 7 percent to $16.3 million. They also expect first-quarter profit between 8 and 9 cents per share on revenue between $23.5 million and $24.5 million. It expects full-year profit of between 67 cents and 71 cents per share on revenue between $108 million and $112 million.
You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com .Gerard@WallStreetGrand.com
Safe Harbor
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.
Disclaimer:
Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.
